Microbial metabolite of dimethylarsinic acid is highly toxic and genotoxic

Toxicology and Applied Pharmacology

Volumn 198, Issue 3, 2004, Pages 345-353

  Kuroda, Koichi ^a   Yoshida, Kaoru ^a   Yoshimura, Mieko ^a   Endo, Yoko ^b   Wanibuchi, Hideki ^a   Fukushima, Shoji ^a   Endo, Ginji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

C mitosis; Chromosomal aberration; Dimethylarsinic acid; Escherichia coli; Mitotic arrest; SCE; Tetraploid

Indexed keywords

ARSENIC DERIVATIVE; CACODYLIC ACID; CYSTEINE; DRINKING WATER; TRIMETHYLARSINE OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL METABOLISM; BACTERIUM ISOLATION; BLADDER; BLADDER TUMOR; CELL SURVIVAL; CHROMATID; CHROMATID ABERRATION; CHROMOSOME ABERRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; FECES; GENOTOXICITY; INTESTINE FLORA; METABOLITE; MITOSIS; NONHUMAN; SISTER CHROMATID EXCHANGE; TETRAPLOIDY; TOXICITY; URINARY EXCRETION; URINE LEVEL;

ESCHERICHIA COLI;

EID: 3242657756     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.10.014     Document Type: Review

References (35)

1. Buchet J.P., Lauwerys R. Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol. Appl. Pharmacol. 91:1987;65-74
2. Cohen S.M., Arnold L.L., Uzvolgyi E., Cano M., John M.S., Yamamoto S., Lu X.F., Le X.C. Possible role of dimethylarsinous acid in dimethylarsinic acid induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15:2002;1150-1157
3. Cullen W.R., McBride B.C., Manji H., Pickett A.W., Reglinski J. The metabolism of methylarsine oxide and sulfide. Appl. Organomet. Chem. 3:1989;71-78
4. Eguchi N., Kuroda K., Endo G. Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells. Arch. Environ. Contam. Toxicol. 32:1997;141-145
5. Endo G., Kuoda K., Okamoto A., Horiguchi S. Dimethylarsinic acid induces tetraploids in Chinese hamster cells. Bull. Environ. Contam. Toxicol. 48:1992;131-137
6. Gebel T.W. Genotoxicity of arsenical compounds. Review. Int. J. Hyg. Environ. Health. 203:2001;249-262
7. Inoue Y., Kawabata K., Takahashi H., Endo G. Determination of arsenic compounds using inductively coupled plasma mass spectrometry with ion chromatography. J. Chromatogr., A. 675:1994;149-154
8. Iwami K., Kuroda K., Endo G. Induction of mitotic arrest and aneuploidy by organic arsenic compounds in human lymphocytes. Appl. Organomet. Chem. 11:1997;743-749
9. Kashiwada E., Kuroda K., Endo G. Aneuploidy induced by dimethylarsinic acid in mouse bone marrow cells. Mutat. Res. 413:1998;33-38
10. Kawata H., Kuroda K., Endo Y., Inoue Y., Endo G. Simple and rapid determination of GTPase activity by capillary electrophoresis without radioisotope. Tohoku J. Exp. Med. 192:2000;69-79
11. Kawata H., Kuroda K., Endo Y., Endo G. Dimethylarsenic acid targets tubulin in mitotic cells to induce abnormal spindles. Appl. Organomet. Chem. 15:2001;676-682
12. Kitamura M., Kuroda K., Endo Y., Endo G. Cysteine enhances clastogenic activity of dimethylarsinic acid. Appl. Organomet. Chem. 16:2002;391-396
13. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172:2001;249-261
14. Kuroda K., Yoshida K., Yasukawa A., Wanibuchi H., Fukushima S., Endo G. Enteric bacteria may play a role in mammalian arsenic metabolism. Appl. Organomet. Chem. 15:2001;548-552
15. Li W., Wanibuchi H., Salim E.I., Yamamoto S., Yoshida K., Endo G., Fukushima S. Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. Cancer Lett. 134:1998;29-36
16. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14:2001;355-361
17. Oya-Ohta Y., Kaise T., Ochi T. Induction of chromosomal aberrations in cultured human fibloblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat. Res. 357:1996;123-129
18. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., Vasken-Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:2000;203-207
19. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutatione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10:1997;27-33
20. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299
21. Styblo M., Drobna Z., Jaspers I., Lin S., Thomas D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect. 110(Suppl. 5):2002;767-771
22. Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact. 88:1993;89-114
23. Tsao D.H.H., Maki A.H. Optically detected magnetic resonance study of the interaction of an arsenic(III) derivative of cacodylic acid with EcoRI methyl transferase. Biochemistry. 30:1991;4565-4572
24. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 82:1999;69-88
25. Vega L., Styblo M., Patterson R., Cullen W.R., Wang C., Germolec D. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 172:2001;225-232
26. Wanibuchi H., Yamamoto S., Chen H., Yoshida K., Endo G., Hori T., Fukushima S. Promoting effects of dimethylarsinic acid on N-butyl-N-(4- hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Carcinogenesis. 17:1996;2435-2439
27. Wanibuchi H., Yamamoto S., Lee C.C.R., Yoshida K., Kuroda K., Endo G., Fukushima S. Promoting effects of organic arsenicals on rat bladder carcinogenesis. Third International Conference on Arsenic Exposure and Health Effects, Book of Abstracts. 1998;112 Society for Environmental Geochemistry and Health
28. Wei M., Wanibuchi H., Yamamoto S., Li W., Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis. 20:1999;1873-1876
29. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., Nakae D., Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis. 23:2002;1387-1397
30. Yamamomto S., Konishi Y., Matsuda T., Murai T., Shibata M., Matsui-Yuasa I., Otani S., Kuroda K., Endo G., Fukushima S. Cancer induction by an organic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55:1995;1271-1276
31. Yamanaka K., Ohba H., Hasegawa A., Sawamura R., Okada S. Mutagenicity of dimethylated metabolites of inorganic arsenics. Chem. Pharm. Bull. 37:1989;2753-2756
32. Yoshida K., Inoue Y., Kuroda K., Chen H., Wanibuchi H., Fukushima S., Endo G. Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats. J. Toxicol. Environ. Health, Part A. 54:1998;179-192
33. Yoshida K., Kuroda K., Inoue Y., Chen H., Date Y., Wanibuchi H., Fukushima S., Endo G. Metabolism of dimethylarsinic acid in rats: production of unidentified metabolites in vivo. Appl. Organomet. Chem. 15:2001;539-547
34. Yoshida K., Kuroda K., Zhou X., Inoue Y., Date Y., Wanibuchi H., Fukushima S., Endo G. Urinary sulfur-containing metabolite produced by intestinal bacteria following oral administration of dimethylarsinic acid to rats. Chem. Res. Toxicol. 16:2003;1124-1129
35. Zhou X., Yoshida K., Kuroda K., Endo Y., Endo G. Effects of cysteine on the cytotoxicity of arsenic compounds. Arch. Environ. Contam. Toxicol. 45:2003;324-330